Skip to main content

Advertisement

Log in

Managing Difficult Pain Conditions in the Cancer Patient

  • Cancer Pain (D Marcus, Section Editor)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Whereas most pain due to cancer can be relieved with relatively simple methods using oral analgesics, as suggested by WHO guidelines, some patients may have difficult pain situations that require more complex approaches. It is estimated that 10–20 % of cancer patients suffer from pain that is not easily relieved. There are a number of factors that may reduce the efficacy of opioids in the management of cancer pain. Neuropathic pain (NP) and breakthrough pain (BP), especially of the incident subtype, have been identified as challenges for clinicians. In several prognostic studies, these two mechanisms were associated with limited positive outcomes compared with other syndromes. Opioid-induced hyperalgesia has recently been described as representing a challenge for physicians in the clinical setting. The global response to opioids, including the development of adverse effects, typically varies by individual and is likely genetically determined. Moreover, clinical evidence suggests that different opioids may produce different effect profiles, and so it is more appropriate to consider the response to each individual opioid rather than general opioid response. This paper will review both pharmacological and procedural mechanisms and treatments of these difficult pain syndromes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of particular importance

  1. Paice JA, Ferrell B. The management of cancer pain. CA Cancer J Clin. 2011;61:157–82.

    Article  PubMed  Google Scholar 

  2. Hanks GW, de Conno F, Cherny N, et al. Expert working group of the research network of the European association for palliative care. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer. 2001;84:587–931.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Fainsinger RL, Nekolaichuk C, Lawlor P, et al. An international muticentre validation study of a pain classification system for cancer patients. Eur J Cancer. 2010;46:2896–904.

    Article  PubMed  Google Scholar 

  4. Knudsen AK, Brunelli C, Kaasa S, et al. Which variables are associated with pain intensity and treatment response in advanced cancer patients? Implications for a future classification system for cancer pain. Eur J Pain. 2011;15:320–7.

    Article  PubMed  Google Scholar 

  5. Mercadante S, Portenoy RK. Opioid poorly-responsive cancer pain. Part 1: clinical considerations. J Pain Symptom Manage. 2001;21:144–50.

    Article  CAS  PubMed  Google Scholar 

  6. Stute P, Soukup J, Menzel M, Sabatowski R, Grond S. Analysis and treatment of different types of neuropathic cancer pain. J Pain Symptom Manage. 2003;26:1123–31.

    Article  PubMed  Google Scholar 

  7. Davis MP. What is new in neuropathic pain? Supp Care Cancer. 2007;15:363–72.

    Article  Google Scholar 

  8. • Jensen TS, Gottrup H, Sindrup SH, Bach FW. The clinical picture of neuropathic pain. Eur J Pharmacol. 2001;429:1–11. Authoritative review of clinical assessment of neuropathic pain.

    Article  CAS  PubMed  Google Scholar 

  9. •• Bennett MI, Smith BH, Torrance N, Lee AJ. Can pain can be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians. Pain. 2006;122:289–94. This paper produced new insights in the concept of neuropathic pain.

    Article  PubMed  Google Scholar 

  10. Fainsinger R, Nekolaichuk C, Lawlor P, Neumann C, Hanson J, Viganò A. A multicenter study of the revised Edmonton staging system for classifying cancer pain in advanced cancer patients. J PainSymptomManage. 2005;29:224–37.

    Google Scholar 

  11. • Mercadante S, Gebbia V, David F, et al. Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients. J Pain. 2009;10:594–600. This paper analyzed the concept of neuropathic pain and the relative opioid response in the clinical setting.

    Article  PubMed  Google Scholar 

  12. Bennett MI. Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: a systematic review. Palliat Med. 2011;25:553–9.

    Article  PubMed  Google Scholar 

  13. Bell RF, Eccleston C, Kalso E. Ketamine as adjuvant to opioids for cancer pain. A qualitative systematic review. J Pain Symptom Manage. 2003;26:867–75.

    Article  CAS  PubMed  Google Scholar 

  14. Hardy J, Quinn S, Fazekas B, et al. Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. J Clin Oncol. 2012;30:3611–7.

    Article  CAS  PubMed  Google Scholar 

  15. Mercadante S. Ketamine: to be or not to be. Ann Palliat Med. 2013;2:37–9.

    Google Scholar 

  16. Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A Comprehensive review of opioid-induced hyperalgesia. Pain Phys. 2011;14:145–61.

    Google Scholar 

  17. Chang G, Chen L, Mao J. Opioid tolerance and hyperalgesia. Med Clin North Am. 2007;91:199–211.

    Article  CAS  PubMed  Google Scholar 

  18. Silverman S. Opioid induced hyperalgesia: clinical implications for the pain practitioner. Pain Phys. 2009;12:679–84.

    Google Scholar 

  19. • Mercadante S, Bruera E. Opioid switching: a systematic and critical review. Cancer Treat Rev. 2006;32:304–15. An outstanding review of opioid switching in cancer pain.

    Article  CAS  PubMed  Google Scholar 

  20. Davies AN, Dickman A, Reid C, Stevens AM, Zeppetella G. The management of cancer-related breakthrough pain: recommendations of a task group of the science committee of the association for palliative medicine of Great Britain and Ireland. Eur J Pain. 2009;13:331–8.

    Article  PubMed  Google Scholar 

  21. Caraceni A, Martini C, Zecca E, et al. Working group of an IASP task force on cancer pain. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Palliat Med. 2004;18:177–83.

    Article  PubMed  Google Scholar 

  22. Nomiya T, Teruyama K, Wada H, Nemoto K. Time course of pain relief in patients treated with radiotherapy for cancer pain: a prospective study. Clin J Pain. 2010;26:38–42.

    Article  PubMed  Google Scholar 

  23. Mercadante S, Villari P, Ferrera P, Casuccio A. Optimization of opioid therapy for preventing incident pain associated with bone metastases. J Pain Symptom Manage. 2004;28:505–10.

    Article  CAS  PubMed  Google Scholar 

  24. • Mercadante S. Pharmacotherapy for breakthrough cancer pain. Drugs. 2012;72:181–90. An updated reviews of drugs used for breakthrough pain.

    Article  CAS  PubMed  Google Scholar 

  25. Mercadante S. Breakthrough pain: on the road again. Eur J Pain. 2009;13:329–30.

    Article  PubMed  Google Scholar 

  26. Mercadante S. Neuraxial techniques for cancer pain: an opinion about unresolved therapeutic dilemmas. Reg Anesth Pain Med. 1999;24:74–83.

    CAS  PubMed  Google Scholar 

  27. Mercadante S, Intravaia G, Villari P, et al. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids. Clin J Pain. 2007;23:793–8.

    Article  PubMed  Google Scholar 

  28. Mercadante S. Malignant bone pain: physiopathology, assessment and treatment. Pain. 1997;69:1–18.

    Article  CAS  PubMed  Google Scholar 

  29. Mercadante S, Fulfaro F. Management of painful bone metastases. Curr Opin Oncol. 2007;19:308–14.

    Article  PubMed  Google Scholar 

  30. Brogan S, Junkins S. Interventional therapies for the management of cancer pain. J Support Oncol. 2010;8:52–9.

    PubMed  Google Scholar 

  31. Biermann JS, Holt GE, Lewis VO, Schwartz HS, Yaszemski MJ. Metastatic bone disease: diagnosis, evaluation and treatment. J Bone Joint Surg Am. 2009;91:1518–30.

    PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Dr. Sebastiano Mercadante declares no potential conflicts of interest relevant to this article.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sebastiano Mercadante.

Additional information

This article is part of the Topical Collection on Cancer Pain

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mercadante, S. Managing Difficult Pain Conditions in the Cancer Patient. Curr Pain Headache Rep 18, 395 (2014). https://doi.org/10.1007/s11916-013-0395-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11916-013-0395-y

Keywords

Navigation